Generate Chart For |
|
|
(Chart displayed below) |
Rat Strains
{{sample.term}}
|
Measurement Methods
{{method.term}}
|
|
|
107 | Solberg Woods LC, et al., Mamm Genome. 2009 Aug 22 | blood insulin amount | | RS:0000916 | WKY/NHsd | female | 119 days | 10 | | CMO:0000342 | plasma insulin level | | | | 20 | mU/l | 2.5 | 7.9057 | MMO:0000164 | intraperitoneal glucose tolerance test | | 0 | | post glucose injection | 60 | min | fasting (for 16 hours) then glucose solution (2 g/kg) | 11614 | fasting (for 16 hours) | glucose solution (2 g/kg) | |
107 | Solberg Woods LC, et al., Mamm Genome. 2009 Aug 22 | blood insulin amount | | RS:0000916 | WKY/NHsd | male | 119 days | 10 | | CMO:0000342 | plasma insulin level | | | | 64.1 | mU/l | 9.7 | 30.6741 | MMO:0000164 | intraperitoneal glucose tolerance test | | 0 | | post glucose injection | 60 | min | fasting (for 16 hours) then glucose solution (2 g/kg) | 11612 | fasting (for 16 hours) | glucose solution (2 g/kg) | |
252 | Baum AE, et al., Endocrinology 2004 Oct 28;. | blood thyroid-stimulating hormone amount | | RS:0000916 | WKY/NHsd | female | 0 days to 70 days | 15 | | CMO:0001248 | serum thyroid stimulating hormone level | | serum tsh | | 3 | ng/ml | 0.0542 | 0.21 | MMO:0000073 | radioimmunoassay | | 0.0 | | | | | naive control condition | 67898 | naive control condition | | |
252 | Baum AE, et al., Endocrinology 2004 Oct 28;. | blood thyroid-stimulating hormone amount | | RS:0000916 | WKY/NHsd | male | 0 days to 70 days | 16 | | CMO:0001248 | serum thyroid stimulating hormone level | | serum tsh | | 5.28 | ng/ml | 0.29 | 1.16 | MMO:0000073 | radioimmunoassay | | 0.0 | | | | | naive control condition | 67897 | naive control condition | | |
2238 | Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. | blood creatinine amount | | RS:0000916 | WKY/NHsd | male | 0 days | 8 | | CMO:0000537 | plasma creatinine level | | | | 0.31787282 | mg/dl | 0.0113 | 0.032 | MMO:0000306 | plasma creatinine analysis | | 0.0 | | | | | controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days) | 99174 | controlled sodium content diet (8 %) (for 8 days) | 0.9% sodium chloride solution (0.9 %) (for 8 days) | sunitinib (7 mg/kg/d) (for 8 days) |
2238 | Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. | blood creatinine amount | | RS:0000916 | WKY/NHsd | male | 0 days | 7 | | CMO:0000537 | plasma creatinine level | | | | 0.30090452 | mg/dl | 0.0079 | 0.021 | MMO:0000306 | plasma creatinine analysis | | 0.0 | | | | | controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then vehicle control condition (0.5 ml) (for 8 days) | 99173 | controlled sodium content diet (8 %) (for 8 days) | 0.9% sodium chloride solution (0.9 %) (for 8 days) | vehicle control condition (0.5 ml) (for 8 days) |
2238 | Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. | blood creatinine amount | | RS:0000916 | WKY/NHsd | male | 0 days | 8 | | CMO:0000537 | plasma creatinine level | | | | 0.35180942 | mg/dl | 0.017 | 0.048 | MMO:0000306 | plasma creatinine analysis | | 0.0 | | | | | standard rat chow (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days) | 99172 | standard rat chow (for 8 days) | sunitinib (7 mg/kg/d) (for 8 days) | |
2238 | Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. | blood creatinine amount | | RS:0000916 | WKY/NHsd | male | 0 days | 7 | | CMO:0000537 | plasma creatinine level | | | | 0.30882306 | mg/dl | 0.0102 | 0.0269 | MMO:0000306 | plasma creatinine analysis | | 0.0 | | | | | standard rat chow (for 8 days) then vehicle control condition (0.5 ml) (for 8 days) | 99171 | standard rat chow (for 8 days) | vehicle control condition (0.5 ml) (for 8 days) | |
141 | Lan H, et al., Genetics 2001 Jan;157(1):331-9 | mammary gland integrity trait | | RS:0000916 | WKY/NHsd | female | 174 days to 169 days | 17 | | CMO:0000343 | mammary tumor number | | 3X3 mm diameter or larger | | 0 | | | | MMO:0000344 | necropsy | | | | | | | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) | 11741 | 7,12-dimethyltetraphene (DMBA) (65 mg/kg) | | |
2238 | Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. | arterial blood pressure trait | | RS:0000916 | WKY/NHsd | male | 0 days | 8 | | CMO:0000009 | mean arterial blood pressure | | | | 124 | mmHg | 4.0 | 11.3137 | MMO:0000577 | intra-aortic radiotelemetry | | 0.0 | | | | | controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days) | 99190 | controlled sodium content diet (8 %) (for 8 days) | 0.9% sodium chloride solution (0.9 %) (for 8 days) | sunitinib (7 mg/kg/d) (for 8 days) |
2238 | Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. | arterial blood pressure trait | | RS:0000916 | WKY/NHsd | male | 0 days | 7 | | CMO:0000009 | mean arterial blood pressure | | | | 116 | mmHg | 1.0 | 2.6458 | MMO:0000577 | intra-aortic radiotelemetry | | 0.0 | | | | | controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then vehicle control condition (0.5 ml) (for 8 days) | 99189 | controlled sodium content diet (8 %) (for 8 days) | 0.9% sodium chloride solution (0.9 %) (for 8 days) | vehicle control condition (0.5 ml) (for 8 days) |
2238 | Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. | arterial blood pressure trait | | RS:0000916 | WKY/NHsd | male | 0 days | 8 | | CMO:0000009 | mean arterial blood pressure | | | | 128 | mmHg | 3.0 | 8.4853 | MMO:0000577 | intra-aortic radiotelemetry | | 0.0 | | | | | standard rat chow (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days) | 99188 | standard rat chow (for 8 days) | sunitinib (7 mg/kg/d) (for 8 days) | |
2238 | Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. | arterial blood pressure trait | | RS:0000916 | WKY/NHsd | male | 0 days | 7 | | CMO:0000009 | mean arterial blood pressure | | | | 101 | mmHg | 0.9 | 2.3812 | MMO:0000577 | intra-aortic radiotelemetry | | 0.0 | | | | | standard rat chow (for 8 days) then vehicle control condition (0.5 ml) (for 8 days) | 99187 | standard rat chow (for 8 days) | vehicle control condition (0.5 ml) (for 8 days) | |
2238 | Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. | blood chloride amount | | RS:0000916 | WKY/NHsd | male | 0 days | 7 | | CMO:0000059 | plasma chloride level | | | | 104.8 | mmol/l | 1.8 | 4.7624 | MMO:0000037 | automated blood electrolyte analysis | | 0.0 | | | | | controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then vehicle control condition (0.5 ml) (for 8 days) | 99169 | controlled sodium content diet (8 %) (for 8 days) | 0.9% sodium chloride solution (0.9 %) (for 8 days) | vehicle control condition (0.5 ml) (for 8 days) |
2238 | Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. | blood chloride amount | | RS:0000916 | WKY/NHsd | male | 0 days | 8 | | CMO:0000059 | plasma chloride level | | | | 109.1 | mmol/l | 1.0 | 2.8284 | MMO:0000037 | automated blood electrolyte analysis | | 0.0 | | | | | controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days) | 99170 | controlled sodium content diet (8 %) (for 8 days) | 0.9% sodium chloride solution (0.9 %) (for 8 days) | sunitinib (7 mg/kg/d) (for 8 days) |
2238 | Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. | blood chloride amount | | RS:0000916 | WKY/NHsd | male | 0 days | 8 | | CMO:0000059 | plasma chloride level | | | | 100.5 | mmol/l | 0.5 | 1.4142 | MMO:0000037 | automated blood electrolyte analysis | | 0.0 | | | | | standard rat chow (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days) | 99168 | standard rat chow (for 8 days) | sunitinib (7 mg/kg/d) (for 8 days) | |
2238 | Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. | blood chloride amount | | RS:0000916 | WKY/NHsd | male | 0 days | 7 | | CMO:0000059 | plasma chloride level | | | | 98.2 | mmol/l | 1.1 | 2.9103 | MMO:0000037 | automated blood electrolyte analysis | | 0.0 | | | | | standard rat chow (for 8 days) then vehicle control condition (0.5 ml) (for 8 days) | 99167 | standard rat chow (for 8 days) | vehicle control condition (0.5 ml) (for 8 days) | |
105 | Solberg LC, et al., Physiol Genomics. 2006 Nov 27;27(3):362-9. Epub 2006 Aug 8 | adrenal gland mass | | RS:0000916 | WKY/NHsd | female | 112 days | 20 | | CMO:0000164 | both adrenal glands wet weight | | | | 65.8 | mg | 1.8 | 8.0498 | MMO:0000005 | post excision weight measurement | | | | | | | naive control condition | 11602 | naive control condition | | |
105 | Solberg LC, et al., Physiol Genomics. 2006 Nov 27;27(3):362-9. Epub 2006 Aug 8 | adrenal gland mass | | RS:0000916 | WKY/NHsd | male | 112 days | 24 | | CMO:0000164 | both adrenal glands wet weight | | | | 43 | mg | 1.2 | 5.8788 | MMO:0000005 | post excision weight measurement | | | | | | | naive control condition | 11600 | naive control condition | | |
107 | Solberg Woods LC, et al., Mamm Genome. 2009 Aug 22 | blood glucose amount | | RS:0000916 | WKY/NHsd | female | 119 days | 10 | | CMO:0000042 | plasma glucose level | | | | 84.3 | mg/dl | 6.9 | 21.8197 | MMO:0000315 | plasma glucose analysis | | 0 | | | | | fasting (for 16 hours) then glucose solution (2 g/kg) | 13184 | fasting (for 16 hours) | glucose solution (2 g/kg) | |
107 | Solberg Woods LC, et al., Mamm Genome. 2009 Aug 22 | blood glucose amount | | RS:0000916 | WKY/NHsd | female | 119 days | 10 | | CMO:0000042 | plasma glucose level | | | | 163.7 | mg/dl | 7.2 | 22.7684 | MMO:0000164 | intraperitoneal glucose tolerance test | | 0 | | post glucose injection | 60 | min | fasting (for 16 hours) then glucose solution (2 g/kg) | 13183 | fasting (for 16 hours) | glucose solution (2 g/kg) | |
107 | Solberg Woods LC, et al., Mamm Genome. 2009 Aug 22 | blood glucose amount | | RS:0000916 | WKY/NHsd | female | 105 days | 10 | | CMO:0000042 | plasma glucose level | | | | 151.6 | mg/dl | 4.7 | 14.8627 | MMO:0000315 | plasma glucose analysis | | 0 | | | | | physical restraint in tube type rodent restrainer (for 0.5 hours) | 13182 | physical restraint in tube type rodent restrainer (for 0.5 hours) | | |
107 | Solberg Woods LC, et al., Mamm Genome. 2009 Aug 22 | blood glucose amount | | RS:0000916 | WKY/NHsd | male | 105 days | 10 | | CMO:0000042 | plasma glucose level | | | | 153.5 | mg/dl | 6.3 | 19.9223 | MMO:0000315 | plasma glucose analysis | | 0 | | | | | physical restraint in tube type rodent restrainer (for 0.5 hours) | 13175 | physical restraint in tube type rodent restrainer (for 0.5 hours) | | |
107 | Solberg Woods LC, et al., Mamm Genome. 2009 Aug 22 | blood glucose amount | | RS:0000916 | WKY/NHsd | male | 119 days | 10 | | CMO:0000042 | plasma glucose level | | | | 98.1 | mg/dl | 2.5 | 7.9057 | MMO:0000315 | plasma glucose analysis | | 0 | | | | | fasting (for 16 hours) then glucose solution (2 g/kg) | 13174 | fasting (for 16 hours) | glucose solution (2 g/kg) | |
107 | Solberg Woods LC, et al., Mamm Genome. 2009 Aug 22 | blood glucose amount | | RS:0000916 | WKY/NHsd | male | 119 days | 10 | | CMO:0000042 | plasma glucose level | | | | 173.8 | mg/dl | 5.5 | 17.3925 | MMO:0000164 | intraperitoneal glucose tolerance test | | 0 | | post glucose injection | 60 | min | fasting (for 16 hours) then glucose solution (2 g/kg) | 13173 | fasting (for 16 hours) | glucose solution (2 g/kg) | |
2238 | Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. | blood sodium amount | | RS:0000916 | WKY/NHsd | male | 0 days | 8 | | CMO:0000060 | plasma sodium level | | | | 139.4 | mmol/l | 1.7 | 4.8083 | MMO:0000037 | automated blood electrolyte analysis | | 0.0 | | | | | controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days) | 99162 | controlled sodium content diet (8 %) (for 8 days) | 0.9% sodium chloride solution (0.9 %) (for 8 days) | sunitinib (7 mg/kg/d) (for 8 days) |
2238 | Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. | blood sodium amount | | RS:0000916 | WKY/NHsd | male | 0 days | 7 | | CMO:0000060 | plasma sodium level | | | | 141.4 | mmol/l | 2.1 | 5.5561 | MMO:0000037 | automated blood electrolyte analysis | | 0.0 | | | | | controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then vehicle control condition (0.5 ml) (for 8 days) | 99161 | controlled sodium content diet (8 %) (for 8 days) | 0.9% sodium chloride solution (0.9 %) (for 8 days) | vehicle control condition (0.5 ml) (for 8 days) |
2238 | Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. | blood sodium amount | | RS:0000916 | WKY/NHsd | male | 0 days | 8 | | CMO:0000060 | plasma sodium level | | | | 137.8 | mmol/l | 2.3 | 6.5054 | MMO:0000037 | automated blood electrolyte analysis | | 0.0 | | | | | standard rat chow (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days) | 99160 | standard rat chow (for 8 days) | sunitinib (7 mg/kg/d) (for 8 days) | |
2238 | Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. | blood sodium amount | | RS:0000916 | WKY/NHsd | male | 0 days | 7 | | CMO:0000060 | plasma sodium level | | | | 143.7 | mmol/l | 4.4 | 11.6413 | MMO:0000037 | automated blood electrolyte analysis | | 0.0 | | | | | standard rat chow (for 8 days) then vehicle control condition (0.5 ml) (for 8 days) | 99159 | standard rat chow (for 8 days) | vehicle control condition (0.5 ml) (for 8 days) | |
2238 | Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. | glomerular filtration trait | | RS:0000916 | WKY/NHsd | male | 0 days | 8 | | CMO:0000765 | creatinine clearance | | | | 3.5 | ml/min | 0.2 | 0.5657 | MMO:0000275 | urine creatinine analysis | | 0.0 | | | | | controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days) | 99182 | controlled sodium content diet (8 %) (for 8 days) | 0.9% sodium chloride solution (0.9 %) (for 8 days) | sunitinib (7 mg/kg/d) (for 8 days) |
2238 | Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. | glomerular filtration trait | | RS:0000916 | WKY/NHsd | male | 0 days | 7 | | CMO:0000765 | creatinine clearance | | | | 3.5 | ml/min | 0.3 | 0.7937 | MMO:0000275 | urine creatinine analysis | | 0.0 | | | | | controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then vehicle control condition (0.5 ml) (for 8 days) | 99181 | controlled sodium content diet (8 %) (for 8 days) | 0.9% sodium chloride solution (0.9 %) (for 8 days) | vehicle control condition (0.5 ml) (for 8 days) |
2238 | Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. | glomerular filtration trait | | RS:0000916 | WKY/NHsd | male | 0 days | 8 | | CMO:0000765 | creatinine clearance | | | | 3.1 | ml/min | 0.5 | 1.4142 | MMO:0000275 | urine creatinine analysis | | 0.0 | | | | | standard rat chow (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days) | 99180 | standard rat chow (for 8 days) | sunitinib (7 mg/kg/d) (for 8 days) | |
2238 | Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. | glomerular filtration trait | | RS:0000916 | WKY/NHsd | male | 0 days | 7 | | CMO:0000765 | creatinine clearance | | | | 3.1 | ml/min | 0.5 | 1.3229 | MMO:0000275 | urine creatinine analysis | | 0.0 | | | | | standard rat chow (for 8 days) then vehicle control condition (0.5 ml) (for 8 days) | 99179 | standard rat chow (for 8 days) | vehicle control condition (0.5 ml) (for 8 days) | |
2238 | Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. | blood potassium amount | | RS:0000916 | WKY/NHsd | male | 0 days | 8 | | CMO:0000061 | plasma potassium level | | | | 4.4 | mmol/l | 0.4 | 1.1314 | MMO:0000037 | automated blood electrolyte analysis | | 0.0 | | | | | controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days) | 99166 | controlled sodium content diet (8 %) (for 8 days) | 0.9% sodium chloride solution (0.9 %) (for 8 days) | sunitinib (7 mg/kg/d) (for 8 days) |
2238 | Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. | blood potassium amount | | RS:0000916 | WKY/NHsd | male | 0 days | 7 | | CMO:0000061 | plasma potassium level | | | | 4.2 | mmol/l | 0.3 | 0.7937 | MMO:0000037 | automated blood electrolyte analysis | | 0.0 | | | | | controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then vehicle control condition (0.5 ml) (for 8 days) | 99165 | controlled sodium content diet (8 %) (for 8 days) | 0.9% sodium chloride solution (0.9 %) (for 8 days) | vehicle control condition (0.5 ml) (for 8 days) |
2238 | Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. | blood potassium amount | | RS:0000916 | WKY/NHsd | male | 0 days | 8 | | CMO:0000061 | plasma potassium level | | | | 4.2 | mmol/l | 0.3 | 0.8485 | MMO:0000037 | automated blood electrolyte analysis | | 0.0 | | | | | standard rat chow (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days) | 99164 | standard rat chow (for 8 days) | sunitinib (7 mg/kg/d) (for 8 days) | |
2238 | Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. | blood potassium amount | | RS:0000916 | WKY/NHsd | male | 0 days | 7 | | CMO:0000061 | plasma potassium level | | | | 3.9 | mmol/l | 0.2 | 0.5292 | MMO:0000037 | automated blood electrolyte analysis | | 0.0 | | | | | standard rat chow (for 8 days) then vehicle control condition (0.5 ml) (for 8 days) | 99163 | standard rat chow (for 8 days) | vehicle control condition (0.5 ml) (for 8 days) | |
107 | Solberg Woods LC, et al., Mamm Genome. 2009 Aug 22 | body mass | | RS:0000916 | WKY/NHsd | female | 119 days | 10 | | CMO:0000012 | body weight | | | | 230 | g | 3.2 | 10.1193 | MMO:0000016 | body weighing method | | 0 | | | | | fasting (for 16 hours) | 11610 | fasting (for 16 hours) | | |
107 | Solberg Woods LC, et al., Mamm Genome. 2009 Aug 22 | body mass | | RS:0000916 | WKY/NHsd | male | 119 days | 10 | | CMO:0000012 | body weight | | | | 352 | g | 4.5 | 14.2302 | MMO:0000016 | body weighing method | | 0 | | | | | fasting (for 16 hours) | 11608 | fasting (for 16 hours) | | |
972 | Baum AE, et al., Behav Brain Res. 2006 Feb 17;. | locomotor behavior trait | | RS:0000916 | WKY/NHsd | female | 88 days to 77 days | 22 | | CMO:0000960 | number of entries into a discrete space in an experimental apparatus | | in 10min; unprompted | | 6.2 | | 1.4284 | 6.7 | MMO:0000258 | open field apparatus method | | 600.0 | | | | | naive control condition | 75706 | naive control condition | | |
972 | Baum AE, et al., Behav Brain Res. 2006 Feb 17;. | locomotor behavior trait | | RS:0000916 | WKY/NHsd | male | 88 days to 77 days | 28 | | CMO:0000960 | number of entries into a discrete space in an experimental apparatus | | in 10min; unprompted | | 4 | | 0.8693 | 4.6 | MMO:0000258 | open field apparatus method | | 600.0 | | | | | naive control condition | 75704 | naive control condition | | |
105 | Solberg LC, et al., Physiol Genomics. 2006 Nov 27;27(3):362-9. Epub 2006 Aug 8 | blood corticosterone amount | | RS:0000916 | WKY/NHsd | female | 105 days | 20 | | CMO:0001173 | plasma corticosterone level | | | | 584.5 | ng/ml | 33.5 | 149.8166 | MMO:0000073 | radioimmunoassay | | 0 | | | | | physical restraint (for 0.2 hours) | 13128 | physical restraint (for 0.2 hours) | | |
105 | Solberg LC, et al., Physiol Genomics. 2006 Nov 27;27(3):362-9. Epub 2006 Aug 8 | blood corticosterone amount | | RS:0000916 | WKY/NHsd | male | 105 days | 24 | | CMO:0001173 | plasma corticosterone level | | ng/ml | | 287.5 | ng/ml | 21.0 | 102.8786 | MMO:0000073 | radioimmunoassay | | 0 | | | | | physical restraint (for 0.2 hours) | 13124 | physical restraint (for 0.2 hours) | | |
105 | Solberg LC, et al., Physiol Genomics. 2006 Nov 27;27(3):362-9. Epub 2006 Aug 8 | blood corticosterone amount | | RS:0000916 | WKY/NHsd | female | 105 days | 20 | | CMO:0001173 | plasma corticosterone level | | | | 113 | ng/ml | 18.9 | 84.5234 | MMO:0000073 | radioimmunoassay | | | | | | | naive control condition | 13121 | naive control condition | | |
105 | Solberg LC, et al., Physiol Genomics. 2006 Nov 27;27(3):362-9. Epub 2006 Aug 8 | blood corticosterone amount | | RS:0000916 | WKY/NHsd | male | 105 days | 24 | | CMO:0001173 | plasma corticosterone level | | ng/ml | | 31.7 | ng/ml | 4.2 | 20.5757 | MMO:0000073 | radioimmunoassay | | | | | | | naive control condition | 13118 | naive control condition | | |
972 | Baum AE, et al., Behav Brain Res. 2006 Feb 17;. | grooming behavior trait | | RS:0000916 | WKY/NHsd | male | 88 days to 77 days | 26 | | CMO:0001749 | duration of grooming in an experimental apparatus | | in 10min | | 82.4 | s | 12.3357 | 62.9 | MMO:0000559 | defensive burying test | | 600.0 | defensive burying apparatus | | | | naive control condition | 75702 | naive control condition | | |
972 | Baum AE, et al., Behav Brain Res. 2006 Feb 17;. | grooming behavior trait | | RS:0000916 | WKY/NHsd | female | 88 days to 77 days | 16 | | CMO:0001749 | duration of grooming in an experimental apparatus | | in 10min | | 97.9 | s | 17.75 | 71.0 | MMO:0000559 | defensive burying test | | 600.0 | defensive burying apparatus | | | | naive control condition | 75700 | naive control condition | | |
972 | Baum AE, et al., Behav Brain Res. 2006 Feb 17;. | grooming behavior trait | | RS:0000916 | WKY/NHsd | female | 88 days to 77 days | 22 | | CMO:0001749 | duration of grooming in an experimental apparatus | | in 10min | | 42.5 | s | 6.1189 | 28.7 | MMO:0000258 | open field apparatus method | | 600.0 | | | | | naive control condition | 75696 | naive control condition | | |
972 | Baum AE, et al., Behav Brain Res. 2006 Feb 17;. | grooming behavior trait | | RS:0000916 | WKY/NHsd | male | 88 days to 77 days | 28 | | CMO:0001749 | duration of grooming in an experimental apparatus | | in 10min | | 35.3 | s | 7.4837 | 39.6 | MMO:0000258 | open field apparatus method | | 600.0 | | | | | naive control condition | 68654 | naive control condition | | |
972 | Baum AE, et al., Behav Brain Res. 2006 Feb 17;. | body movement coordination trait | | RS:0000916 | WKY/NHsd | female | 88 days to 77 days | 22 | | CMO:0001752 | number of rearing movements in an experimental apparatus | | in 10min | | 20.5 | | 2.2599 | 10.6 | MMO:0000258 | open field apparatus method | | 600.0 | | | | | naive control condition | 75692 | naive control condition | | |
972 | Baum AE, et al., Behav Brain Res. 2006 Feb 17;. | body movement coordination trait | | RS:0000916 | WKY/NHsd | male | 88 days to 77 days | 28 | | CMO:0001752 | number of rearing movements in an experimental apparatus | | in 10min | | 9.6 | | 1.3796 | 7.3 | MMO:0000258 | open field apparatus method | | 600.0 | | | | | naive control condition | 75698 | naive control condition | | |
972 | Baum AE, et al., Behav Brain Res. 2006 Feb 17;. | body movement coordination trait | | RS:0000916 | WKY/NHsd | male | 88 days to 77 days | 26 | | CMO:0001752 | number of rearing movements in an experimental apparatus | | in 10min | | 17.8 | | 1.4513 | 7.4 | MMO:0000559 | defensive burying test | | 600.0 | defensive burying apparatus | | | | naive control condition | 75694 | naive control condition | | |
972 | Baum AE, et al., Behav Brain Res. 2006 Feb 17;. | body movement coordination trait | | RS:0000916 | WKY/NHsd | female | 88 days to 77 days | 16 | | CMO:0001752 | number of rearing movements in an experimental apparatus | | in 10min | | 33.8 | | 2.65 | 10.6 | MMO:0000559 | defensive burying test | | 600.0 | defensive burying apparatus | | | | naive control condition | 68652 | naive control condition | | |
2238 | Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. | skin potassium amount | | RS:0000916 | WKY/NHsd | male | 0 days | 8 | | CMO:0002773 | skin potassium level to skin water level ratio | | skin k/h2o | | 69 | mmol/l | 2.5 | 7.0711 | MMO:0000584 | ex vivo analysis of atomic composition following dry ashing | | 0.0 | ashed skin | | | | controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days) | 99158 | controlled sodium content diet (8 %) (for 8 days) | 0.9% sodium chloride solution (0.9 %) (for 8 days) | sunitinib (7 mg/kg/d) (for 8 days) |
2238 | Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. | skin potassium amount | | RS:0000916 | WKY/NHsd | male | 0 days | 7 | | CMO:0002773 | skin potassium level to skin water level ratio | | skin k/h2o | | 71 | mmol/l | 3.0 | 7.9373 | MMO:0000584 | ex vivo analysis of atomic composition following dry ashing | | 0.0 | ashed skin | | | | controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then vehicle control condition (0.5 ml) (for 8 days) | 99157 | controlled sodium content diet (8 %) (for 8 days) | 0.9% sodium chloride solution (0.9 %) (for 8 days) | vehicle control condition (0.5 ml) (for 8 days) |
2238 | Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. | skin potassium amount | | RS:0000916 | WKY/NHsd | male | 0 days | 8 | | CMO:0002773 | skin potassium level to skin water level ratio | | skin k/h2o | | 75 | mmol/l | 1.8 | 5.0912 | MMO:0000584 | ex vivo analysis of atomic composition following dry ashing | | 0.0 | ashed skin | | | | standard rat chow (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days) | 99156 | standard rat chow (for 8 days) | sunitinib (7 mg/kg/d) (for 8 days) | |
2238 | Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. | skin potassium amount | | RS:0000916 | WKY/NHsd | male | 0 days | 7 | | CMO:0002773 | skin potassium level to skin water level ratio | | skin k/h2o | | 80 | mmol/l | 1.1 | 2.9103 | MMO:0000584 | ex vivo analysis of atomic composition following dry ashing | | 0.0 | ashed skin | | | | standard rat chow (for 8 days) then vehicle control condition (0.5 ml) (for 8 days) | 99155 | standard rat chow (for 8 days) | vehicle control condition (0.5 ml) (for 8 days) | |
2238 | Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. | skin mineral amount | | RS:0000916 | WKY/NHsd | male | 0 days | 8 | | CMO:0002772 | skin potassium level plus skin sodium level to skin water level ratio | | skin na+k/h2o | | 0.171 | | 0.004 | 0.0113 | MMO:0000584 | ex vivo analysis of atomic composition following dry ashing | | 0.0 | ashed skin | | | | controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days) | 99146 | controlled sodium content diet (8 %) (for 8 days) | 0.9% sodium chloride solution (0.9 %) (for 8 days) | sunitinib (7 mg/kg/d) (for 8 days) |
2238 | Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. | skin mineral amount | | RS:0000916 | WKY/NHsd | male | 0 days | 7 | | CMO:0002772 | skin potassium level plus skin sodium level to skin water level ratio | | skin na+k/h2o | | 0.176 | | 0.008 | 0.0212 | MMO:0000584 | ex vivo analysis of atomic composition following dry ashing | | 0.0 | ashed skin | | | | controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then vehicle control condition (0.5 ml) (for 8 days) | 99145 | controlled sodium content diet (8 %) (for 8 days) | 0.9% sodium chloride solution (0.9 %) (for 8 days) | vehicle control condition (0.5 ml) (for 8 days) |
2238 | Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. | skin mineral amount | | RS:0000916 | WKY/NHsd | male | 0 days | 8 | | CMO:0002772 | skin potassium level plus skin sodium level to skin water level ratio | | skin na+k/h2o | | 0.167 | | 0.003 | 0.0085 | MMO:0000584 | ex vivo analysis of atomic composition following dry ashing | | 0.0 | ashed skin | | | | standard rat chow (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days) | 99144 | standard rat chow (for 8 days) | sunitinib (7 mg/kg/d) (for 8 days) | |
2238 | Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. | skin mineral amount | | RS:0000916 | WKY/NHsd | male | 0 days | 7 | | CMO:0002772 | skin potassium level plus skin sodium level to skin water level ratio | | skin na+k/h2o | | 0.17 | | 0.001 | 0.0026 | MMO:0000584 | ex vivo analysis of atomic composition following dry ashing | | 0.0 | ashed skin | | | | standard rat chow (for 8 days) then vehicle control condition (0.5 ml) (for 8 days) | 99143 | standard rat chow (for 8 days) | vehicle control condition (0.5 ml) (for 8 days) | |
2238 | Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. | blood cystatin C amount | | RS:0000916 | WKY/NHsd | male | 0 days | 8 | | CMO:0002778 | plasma cystatin C level | | | | 3.9 | mg/l | 0.3 | 0.8485 | MMO:0000352 | automated plasma protein analysis | | 0.0 | | | | | controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days) | 99178 | controlled sodium content diet (8 %) (for 8 days) | 0.9% sodium chloride solution (0.9 %) (for 8 days) | sunitinib (7 mg/kg/d) (for 8 days) |
2238 | Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. | blood cystatin C amount | | RS:0000916 | WKY/NHsd | male | 0 days | 7 | | CMO:0002778 | plasma cystatin C level | | | | 3.5 | mg/l | 0.2 | 0.5292 | MMO:0000352 | automated plasma protein analysis | | 0.0 | | | | | controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then vehicle control condition (0.5 ml) (for 8 days) | 99177 | controlled sodium content diet (8 %) (for 8 days) | 0.9% sodium chloride solution (0.9 %) (for 8 days) | vehicle control condition (0.5 ml) (for 8 days) |
2238 | Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. | blood cystatin C amount | | RS:0000916 | WKY/NHsd | male | 0 days | 8 | | CMO:0002778 | plasma cystatin C level | | plasma cystatin c | | 4.7 | mg/l | 0.3 | 0.8485 | MMO:0000352 | automated plasma protein analysis | | 0.0 | | | | | standard rat chow (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days) | 99176 | standard rat chow (for 8 days) | sunitinib (7 mg/kg/d) (for 8 days) | |
2238 | Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. | blood cystatin C amount | | RS:0000916 | WKY/NHsd | male | 0 days | 7 | | CMO:0002778 | plasma cystatin C level | | | | 4 | mg/l | 0.6 | 1.5875 | MMO:0000352 | automated plasma protein analysis | | 0.0 | | | | | standard rat chow (for 8 days) then vehicle control condition (0.5 ml) (for 8 days) | 99175 | standard rat chow (for 8 days) | vehicle control condition (0.5 ml) (for 8 days) | |
2238 | Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. | urine sodium amount | | RS:0000916 | WKY/NHsd | male | 0 days | 8 | | CMO:0000760 | urine sodium excretion rate | | | | 34.3 | mEq/d | 1.8 | 5.0912 | MMO:0000434 | urine sodium analysis | | 0.0 | | | | | controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days) | 99186 | controlled sodium content diet (8 %) (for 8 days) | 0.9% sodium chloride solution (0.9 %) (for 8 days) | sunitinib (7 mg/kg/d) (for 8 days) |
2238 | Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. | urine sodium amount | | RS:0000916 | WKY/NHsd | male | 0 days | 7 | | CMO:0000760 | urine sodium excretion rate | | | | 41.9 | mEq/d | 5.2 | 13.7579 | MMO:0000434 | urine sodium analysis | | 0.0 | | | | | controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then vehicle control condition (0.5 ml) (for 8 days) | 99185 | controlled sodium content diet (8 %) (for 8 days) | 0.9% sodium chloride solution (0.9 %) (for 8 days) | vehicle control condition (0.5 ml) (for 8 days) |
2238 | Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. | urine sodium amount | | RS:0000916 | WKY/NHsd | male | 0 days | 8 | | CMO:0000760 | urine sodium excretion rate | | | | 1.1 | mEq/d | 0.1 | 0.2828 | MMO:0000434 | urine sodium analysis | | 0.0 | | | | | standard rat chow (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days) | 99184 | standard rat chow (for 8 days) | sunitinib (7 mg/kg/d) (for 8 days) | |
2238 | Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. | urine sodium amount | | RS:0000916 | WKY/NHsd | male | 0 days | 7 | | CMO:0000760 | urine sodium excretion rate | | mmol/d | | 1 | mEq/d | 0.2 | 0.5292 | MMO:0000434 | urine sodium analysis | | 0.0 | | | | | standard rat chow (for 8 days) then vehicle control condition (0.5 ml) (for 8 days) | 99183 | standard rat chow (for 8 days) | vehicle control condition (0.5 ml) (for 8 days) | |
2238 | Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. | skin water amount | | RS:0000916 | WKY/NHsd | male | 0 days | 8 | | CMO:0002771 | skin water level to skin dry weight ratio | | skin h2o ml/g | | 1.522 | ml/g | 0.004 | 0.0113 | MMO:0000584 | ex vivo analysis of atomic composition following dry ashing | | 0.0 | ashed skin | | | | controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days) | 99142 | controlled sodium content diet (8 %) (for 8 days) | 0.9% sodium chloride solution (0.9 %) (for 8 days) | sunitinib (7 mg/kg/d) (for 8 days) |
2238 | Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. | skin water amount | | RS:0000916 | WKY/NHsd | male | 0 days | 7 | | CMO:0002771 | skin water level to skin dry weight ratio | | skin h2o ml/g | | 1.432 | ml/g | 0.032 | 0.0847 | MMO:0000584 | ex vivo analysis of atomic composition following dry ashing | | 0.0 | ashed skin | | | | controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then vehicle control condition (0.5 ml) (for 8 days) | 99141 | controlled sodium content diet (8 %) (for 8 days) | 0.9% sodium chloride solution (0.9 %) (for 8 days) | vehicle control condition (0.5 ml) (for 8 days) |
2238 | Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. | skin water amount | | RS:0000916 | WKY/NHsd | male | 0 days | 8 | | CMO:0002771 | skin water level to skin dry weight ratio | | skin h2o ml/g | | 1.208 | ml/g | 0.019 | 0.0537 | MMO:0000584 | ex vivo analysis of atomic composition following dry ashing | | 0.0 | ashed skin | | | | standard rat chow (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days) | 99140 | standard rat chow (for 8 days) | sunitinib (7 mg/kg/d) (for 8 days) | |
2238 | Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. | skin water amount | | RS:0000916 | WKY/NHsd | male | 0 days | 7 | | CMO:0002771 | skin water level to skin dry weight ratio | | skin h2o ml/g | | 1.223 | ml/g | 0.032 | 0.0847 | MMO:0000584 | ex vivo analysis of atomic composition following dry ashing | | 0.0 | ashed skin | | | | standard rat chow (for 8 days) then sunitinib (0.5 ml) (for 8 days) | 99139 | standard rat chow (for 8 days) | sunitinib (0.5 ml) (for 8 days) | |
2238 | Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. | skin sodium amount | | RS:0000916 | WKY/NHsd | male | 0 days | 8 | | CMO:0002769 | skin sodium level to skin dry weight ratio | | mmol/g | | 0.164 | REQUEST NEW VALUE | 0.009 | 0.0255 | MMO:0000584 | ex vivo analysis of atomic composition following dry ashing | | 0.0 | ashed skin | | | | controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days) | 99134 | controlled sodium content diet (8 %) (for 8 days) | 0.9% sodium chloride solution (0.9 %) (for 8 days) | sunitinib (7 mg/kg/d) (for 8 days) |
2238 | Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. | skin sodium amount | | RS:0000916 | WKY/NHsd | male | 0 days | 7 | | CMO:0002769 | skin sodium level to skin dry weight ratio | | mmol/g | | 0.144 | REQUEST NEW VALUE | 0.005 | 0.0132 | MMO:0000584 | ex vivo analysis of atomic composition following dry ashing | | 0.0 | ashed skin | | | | controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then vehicle control condition (0.5 ml) (for 8 days) | 99133 | controlled sodium content diet (8 %) (for 8 days) | 0.9% sodium chloride solution (0.9 %) (for 8 days) | vehicle control condition (0.5 ml) (for 8 days) |
2238 | Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. | skin sodium amount | | RS:0000916 | WKY/NHsd | male | 0 days | 8 | | CMO:0002769 | skin sodium level to skin dry weight ratio | | mmol/g | | 0.112 | REQUEST NEW VALUE | 0.002 | 0.0057 | MMO:0000584 | ex vivo analysis of atomic composition following dry ashing | | 0.0 | ashed skin | | | | standard rat chow (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days) | 99132 | standard rat chow (for 8 days) | sunitinib (7 mg/kg/d) (for 8 days) | |
2238 | Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. | skin sodium amount | | RS:0000916 | WKY/NHsd | male | 0 days | 7 | | CMO:0002769 | skin sodium level to skin dry weight ratio | | mmol/g | | 0.11 | REQUEST NEW VALUE | 0.003 | 0.0079 | MMO:0000584 | ex vivo analysis of atomic composition following dry ashing | | 0.0 | ashed skin | | | | standard rat chow (for 8 days) then vehicle control condition (0.5 ml) (for 8 days) | 99131 | standard rat chow (for 8 days) | vehicle control condition (0.5 ml) (for 8 days) | |
2238 | Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. | skin chloride amount | | RS:0000916 | WKY/NHsd | male | 0 days | 8 | | CMO:0002770 | skin chloride level to skin dry weight ratio | | skin cl mmol/g | | 0.073 | mmol/g | 0.007 | 0.0198 | MMO:0000584 | ex vivo analysis of atomic composition following dry ashing | | 0.0 | ashed skin | | | | controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days) | 99138 | controlled sodium content diet (8 %) (for 8 days) | 0.9% sodium chloride solution (0.9 %) (for 8 days) | sunitinib (7 mg/kg/d) (for 8 days) |
2238 | Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. | skin chloride amount | | RS:0000916 | WKY/NHsd | male | 0 days | 7 | | CMO:0002770 | skin chloride level to skin dry weight ratio | | skin cl mmol/g | | 0.068 | mmol/g | 0.006 | 0.0159 | MMO:0000584 | ex vivo analysis of atomic composition following dry ashing | | 0.0 | ashed skin | | | | controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then vehicle control condition (0.5 ml) (for 8 days) | 99137 | controlled sodium content diet (8 %) (for 8 days) | 0.9% sodium chloride solution (0.9 %) (for 8 days) | vehicle control condition (0.5 ml) (for 8 days) |
2238 | Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. | skin chloride amount | | RS:0000916 | WKY/NHsd | male | 0 days | 8 | | CMO:0002770 | skin chloride level to skin dry weight ratio | | skin cl mmol/g | | 0.052 | mmol/g | 0.003 | 0.0085 | MMO:0000584 | ex vivo analysis of atomic composition following dry ashing | | 0.0 | ashed skin | | | | standard rat chow (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days) | 99136 | standard rat chow (for 8 days) | sunitinib (7 mg/kg/d) (for 8 days) | |
2238 | Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. | skin chloride amount | | RS:0000916 | WKY/NHsd | male | 0 days | 7 | | CMO:0002770 | skin chloride level to skin dry weight ratio | | skin cl mmol/g | | 0.051 | mmol/g | 0.003 | 0.0079 | MMO:0000584 | ex vivo analysis of atomic composition following dry ashing | | 0.0 | ashed skin | | | | standard rat chow (for 8 days) then vehicle control condition (0.5 ml) (for 8 days) | 99135 | standard rat chow (for 8 days) | vehicle control condition (0.5 ml) (for 8 days) | |
2238 | Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. | skin chloride amount | | RS:0000916 | WKY/NHsd | male | 0 days | 8 | | CMO:0002775 | skin chloride level to skin water level ratio | | skin cl/h2o | | 50 | mmol/l | 4.4 | 12.4451 | MMO:0000584 | ex vivo analysis of atomic composition following dry ashing | | 0.0 | ashed skin | | | | controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days) | 99154 | controlled sodium content diet (8 %) (for 8 days) | 0.9% sodium chloride solution (0.9 %) (for 8 days) | sunitinib (7 mg/kg/d) (for 8 days) |
2238 | Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. | skin chloride amount | | RS:0000916 | WKY/NHsd | male | 0 days | 7 | | CMO:0002775 | skin chloride level to skin water level ratio | | skin cl/h2o | | 48 | mmol/l | 4.8 | 12.6996 | MMO:0000584 | ex vivo analysis of atomic composition following dry ashing | | 0.0 | ashed skin | | | | controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then vehicle control condition (0.5 ml) (for 8 days) | 99153 | controlled sodium content diet (8 %) (for 8 days) | 0.9% sodium chloride solution (0.9 %) (for 8 days) | vehicle control condition (0.5 ml) (for 8 days) |
2238 | Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. | skin chloride amount | | RS:0000916 | WKY/NHsd | male | 0 days | 8 | | CMO:0002775 | skin chloride level to skin water level ratio | | skin cl/h2o | | 43 | mmol/l | 1.5 | 4.2426 | MMO:0000584 | ex vivo analysis of atomic composition following dry ashing | | 0.0 | ashed skin | | | | standard rat chow (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days) | 99152 | standard rat chow (for 8 days) | sunitinib (7 mg/kg/d) (for 8 days) | |
2238 | Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. | skin chloride amount | | RS:0000916 | WKY/NHsd | male | 0 days | 7 | | CMO:0002775 | skin chloride level to skin water level ratio | | skin cl/h2o | | 42 | mmol/l | 2.4 | 6.3498 | MMO:0000584 | ex vivo analysis of atomic composition following dry ashing | | 0.0 | ashed skin | | | | standard rat chow (for 8 days) then vehicle control condition (0.5 ml) (for 8 days) | 99151 | standard rat chow (for 8 days) | vehicle control condition (0.5 ml) (for 8 days) | |
2238 | Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. | skin chloride amount | | RS:0000916 | WKY/NHsd | male | 0 days | 8 | | CMO:0002775 | skin chloride level to skin water level ratio | | skin na/h2o | | 108 | mmol/l | 4.4 | 12.4451 | MMO:0000584 | ex vivo analysis of atomic composition following dry ashing | | 0.0 | ashed skin | | | | controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days) | 99150 | controlled sodium content diet (8 %) (for 8 days) | 0.9% sodium chloride solution (0.9 %) (for 8 days) | sunitinib (7 mg/kg/d) (for 8 days) |
2238 | Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. | skin chloride amount | | RS:0000916 | WKY/NHsd | male | 0 days | 7 | | CMO:0002775 | skin chloride level to skin water level ratio | | skin na/h2o | | 101 | mmol/l | 3.9 | 10.3184 | MMO:0000584 | ex vivo analysis of atomic composition following dry ashing | | 0.0 | ashed skin | | | | controlled sodium content diet (8 %) (for 8 days) then 0.9% sodium chloride solution (0.9 %) (for 8 days) then vehicle control condition (0.5 ml) (for 8 days) | 99149 | controlled sodium content diet (8 %) (for 8 days) | 0.9% sodium chloride solution (0.9 %) (for 8 days) | vehicle control condition (0.5 ml) (for 8 days) |
2238 | Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. | skin chloride amount | | RS:0000916 | WKY/NHsd | male | 0 days | 8 | | CMO:0002775 | skin chloride level to skin water level ratio | | skin na/h2o | | 92 | mmol/l | 1.5 | 4.2426 | MMO:0000584 | ex vivo analysis of atomic composition following dry ashing | | 0.0 | ashed skin | | | | standard rat chow (for 8 days) then sunitinib (7 mg/kg/d) (for 8 days) | 99148 | standard rat chow (for 8 days) | sunitinib (7 mg/kg/d) (for 8 days) | |
2238 | Lankhorst S, et al., Hypertension. 2017 May;69(5):919-926. doi: 10.1161/HYPERTENSIONAHA.116.08565. Epub 2017 Mar 20. | skin chloride amount | | RS:0000916 | WKY/NHsd | male | 0 days | 7 | | CMO:0002775 | skin chloride level to skin water level ratio | | skin na/h2o | | 90 | mmol/l | 0.8 | 2.1166 | MMO:0000584 | ex vivo analysis of atomic composition following dry ashing | | 0.0 | ashed skin | | | | standard rat chow (for 8 days) then vehicle control condition (0.5 ml) (for 8 days) | 99147 | standard rat chow (for 8 days) | vehicle control condition (0.5 ml) (for 8 days) | |